Harry Sloan is Director at DraftKings Inc. (DKNG). They have made 22 open-market trades across 8 companies since 2012, most recently 2026-09-15.
CIK 0001258248
19 open-market purchases totalling $15.6M since 2015, against 3 sales. Across 19 scored buys the stock is down 16.7% at ninety days, and 15.1 points behind the S&P over the same stretch.
19 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 42% | 42% | 26% |
| Avg Move | -3.5% | -1.7% | -16.7% |
| Alpha | -3.2% | -2.4% | -15.1% |
| Scored | 19 | 19 | 19 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DKNG | BUY | 2026-02-17 | 2026-02-18 | $21.85 | $2.2M | +3.5% | +2.9% | +11.0% |
| DKNG | BUY | 2025-11-11 | 2025-11-12 | $30.30 | $758K | -4.7% | +15.0% | -12.2% |
| STRZ | BUY | 2025-08-19 | 2025-08-21 | $12.71 | $285K | -3.2% | +9.5% | -17.6% |
| DKNG | SELL | 2024-06-14 | 2024-06-14 | $38.15 | $9.5M | -4.7% | +1.4% | -0.9% |
| DNA | BUY | 2024-05-14 | 2024-05-14 | $0.91 | $542K | -26.4% | -48.6% | -70.8% |
| DNA | BUY | 2023-05-18 | 2023-05-22 | $1.28 | $448K | +5.2% | +14.9% | +7.8% |
| LGF.B | BUY | 2022-11-22 | 2022-11-22 | $6.40 | $640K | +8.3% | -10.6% | +45.4% |
| LGF.A | BUY | 2022-09-29 | 2022-10-03 | $7.06 | $353K | -10.5% | +0.8% | -30.3% |
| LGF.B | BUY | 2022-04-22 | 2022-04-25 | $12.72 | $636K | -6.1% | -24.6% | -31.6% |
| DKNG | BUY | 2022-03-14 | 2022-03-16 | $15.39 | $770K | +4.9% | -10.1% | -34.7% |
| SKLZ | BUY | 2022-03-14 | 2022-03-15 | $2.27 | $227K | +25.8% | -1.6% | -42.2% |
| SKLZ | BUY | 2022-02-28 | 2022-03-02 | $3.10 | $294K | -28.1% | -0.7% | -36.5% |
| DKNG | BUY | 2022-02-23 | 2022-02-25 | $20.05 | $802K | -21.0% | -17.1% | -36.7% |
| LGF.B | BUY | 2022-02-15 | 2022-02-17 | $12.95 | $1.0M | +14.5% | +20.0% | -5.5% |
| DKNG | BUY | 2021-11-16 | 2021-11-18 | $39.52 | $4.0M | -14.7% | -23.8% | -37.2% |
| SKLZ | BUY | 2021-11-09 | 2021-11-10 | $12.48 | $998K | -19.5% | -27.6% | -66.4% |
| DKNG | SELL | 2020-06-23 | 2020-06-25 | $38.80 | $43.4M | -10.0% | -4.6% | +36.2% |
| ENT | BUY | 2019-05-20 | 2019-05-22 | $1.03 | $5K | -44.0% | -25.6% | -33.7% |
| ENT | BUY | 2018-05-21 | 2018-05-22 | $1.59 | $398K | +26.4% | +47.2% | +36.0% |
| ENT | BUY | 2018-05-18 | 2018-05-21 | $1.38 | $345K | +31.5% | +56.0% | +45.7% |
| EAGL | BUY | 2015-02-11 | 2015-02-13 | $10.00 | $995K | -9.0% | -7.3% | -7.3% |
| EAGL | SELL | 2012-05-08 | 2012-05-08 | $0.01 | $100 | -9.0% | -7.3% | -7.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| STRZ |
| 47,013 |
| $1.1M |
| LGF.B | 58,828 | $452K |
| Total | $195.5M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.